Cytometry Part B-Clinical Cytometry

Papers
(The TQCC of Cytometry Part B-Clinical Cytometry is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Issue highlights—January 202544
Mass cytometric single cell immune profiles of peripheral blood from acute myeloid leukemia patients in complete remission with measurable residual disease42
30
The role of the primitive marker CD133 in CD34‐negative acute myeloid leukemia for the detection of leukemia stem cells28
An uncommon case of acute megakaryoblastic leukemia with DDX3X :: MLLT10 28
18
18
Standardization of flow cytometric detection of antigen expression17
Issue highlights—September 202317
Addition of CD14 improves discrimination of lymphocytes in the TBNK phenotyping panel16
Phenotype and oxidative burst of low‐density neutrophil subpopulations are altered in common variable immunodeficiency patients16
Issue Information15
15
Frequency and stability of populations of CD4+ and CD4+CD25+Foxp3+CD127lo Treg in healthy adults defi14
Machine learning optimized multiparameter radar plots for B‐cell acute lymphoblastic leukemia minimal residual disease analysis14
Utility of leukocyte‐associated immunoglobulin‐like receptor‐1 (CD305) in flow cytometric detection of minimal bone marrow involvement by B‐cell non‐Hodgkin lymphoma13
A 20‐color 21‐antigen flow cytometric assay for disease monitoring of T‐cell lymphoblastic leukemia12
Issue Information12
Defining atypical chronic lymphocytic leukemia for reproducible diagnosis: implications of the work by Wang et al.12
Issue Information11
Issue Information10
Basophilic blast crisis of chronic myelogenous leukemia presenting de novo: Diagnostic contribution of flow cytometry10
ROR1 expression in mature B lymphoid neoplasms by flow cytometry9
Whole blood no‐lyse no‐wash micromethod for the quantitative measurement of monocyte HLA‐DR9
A novel flow cytometry approach to quantify malaria‐derived particles9
Issue Information9
CD133 in T ‐lymphoblastic leukemia is preferentially expressed in early T 9
Converting an HLA‐B27 flow assay from the BD FACSCanto to the BD FACSLyric9
Summary of validation considerations with real‐life examples using both qualitative and semiquantitative flow cytometry assays8
Issue Information8
Integration of T‐cell clonality screening using TRBC‐1 in lymphoma suspect samples by flow cytometry8
Alignment, segmentation and neighborhood analysis in cyclic immunohistochemistry data using CASSATT8
Integrating immune profiling and clinical features for early prediction of chronicity in pediatric immune thrombocytopenia8
Appropriate interpretation of TRBC1‐dim positive subsets in T‐cell immunophenotyping by flow cytometry7
Implementation of a one‐tube flow cytometry panel for measurable residual disease detection in multiple myeloma patients in clinical routine7
Enhancing HLA‐B27 antigen detection: Leveraging machine learning algorithms for flow cytometric analysis7
7
SingletSeeker: An unsupervised clustering approach for automated singlet discrimination in cytometry7
Performance of a novel eight‐color flow cytometry panel for measurable residual disease assessment of chronic lymphocytic leukemia7
Issue Information6
Anti‐ CD38 VHH antibody ( JK36 ) reliably detects CD38 6
6
Correction to “Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet6
International Clinical Cytometry Society 2023 workload survey of clinical flow cytometry laboratories6
Remembering Dr. Bruce H. Davis: A passionate leader in clinical flow cytometry5
Implementation of beaker CP for flow cytometry: Workflow optimization and integration at Stanford Health Care5
Exercise affects systemic basophil responses in humans: Applying an automated and modified basophil activation test ( mBAT ) in a field study5
Monocyte maturation pattern by flow cytometry expression of CD64, CD300e, and CD14 correlates to presence of myeloid neoplasm and helps identify blast equivalents in t5
Editorial on IVD cellular assay validation5
Extranodal NK/T‐cell lymphoma with isolated central nervous system relapse: A defiant disease and the role of flow cytometry in monitoring5
Possible alternative strategies to implement basophil activation testing in multicentric studies5
The patterns and diagnostic significance of the lack of surface immunoglobulin light chain on mature B cells in clinical samples for lymphoma workup5
Prospective validation of podoplanin expression as a diagnostic biomarker of acute promyelocytic leukemia5
Optimizing the diagnosis of chronic granulomatous disease using dihydrorhodamine‐123 assay: Lessons from a large monocentric cohort5
Automated analysis of flow cytometry data with minimal training files: Research evaluation of an elastic image registration algorithm for TBNK, stem cell enumeration, and lymphoid screening5
Clinical significance of end of induction measurable residual disease monitoring in B‐cell acute lymphoblastic leukemia: A single center experience5
Issue Highlights—July 20225
Intraoperative flow cytometry in detecting free carcinoma cells in peritoneal lavage fluid of gastric carcinoma cases5
Flow cytometry‐based monitoring of chimeric antigen receptor ( CAR ) T cells: Reagent selection, assay design, and clinical utility5
Ad hoc antibody modification of a validated flow cytometric immunophenotyping panel—recommendations and safeguards for clinical laboratories5
Characterization of CD123 expression by mast cells in systemic mastocytosis with multicolor flow cytometry5
Monocyte HLA‐DR expression as an enrollment biomarker in sepsis clinical trials: Evaluation of two sampling tubes and definition of respective clinical thresholds5
Issue Information4
Signal without noise: Practical antibody titration for platelet flow cytometry4
Stabilization of bronchoalveolar lavage cells for postponed flow cytometric analysis4
Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry4
Analysis of immunophenotypic changes in acute megakaryoblastic leukemia after treatment4
4
A lasso and random forest model using flow cytometry data identifies primary myelofibrosis4
Increased IFN‐γ+ and TNF‐α+ mucosal‐associated invariant T cells in patients with aplastic anemia4
Issue Highlights—July 20254
4
Flow cytometric immunophenotypic differentiation patterns of bone marrow eosinophilopoiesis4
CD38, CD39, and BCL2 differentiate disseminated forms of high‐grade B‐cell lymphomas in biological fluids from Burkitt lymphoma and diffuse large B‐cell lymphoma4
Glucose‐6‐phosphate dehydrogenase deficiency detection using fluorocytometric assay: Evaluation after 1 year of clinical implementation4
Issue highlights—November 20244
Issue Highlights—November 20254
28‐color single tube for flow cytometric assessment of myeloid maturation, myeloid neoplasia, and acute myeloid leukemia minimal/measurable residual disease4
0.54059386253357